title: Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.
authors.forename: L
authors.initials: L
authors.lastname: Gossec
authors.forename: J W J
authors.initials: JW
authors.lastname: Bijlsma
authors.forename: C
authors.initials: C
authors.lastname: Bombardier
authors.forename: H
authors.initials: H
authors.lastname: Canhão
authors.forename: J
authors.initials: J
authors.lastname: Devlin
authors.forename: C J
authors.initials: CJ
authors.lastname: Edwards
authors.forename: V
authors.initials: V
authors.lastname: Hamuryudan
authors.forename: T K
authors.initials: TK
authors.lastname: Kvien
authors.forename: B F
authors.initials: BF
authors.lastname: Leeb
authors.forename: E M
authors.initials: EM
authors.lastname: Martín-Mola
authors.forename: H
authors.initials: H
authors.lastname: Mielants
authors.forename: U
authors.initials: U
authors.lastname: Müller-Ladner
authors.forename: M
authors.initials: M
authors.lastname: Ostergaard
authors.forename: I A
authors.initials: IA
authors.lastname: Pereira
authors.forename: C
authors.initials: C
authors.lastname: Ramos-Remus
authors.forename: J
authors.initials: J
authors.lastname: Zochling
authors.forename: Maxime
authors.initials: M
authors.lastname: Dougados
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D033181:Information Dissemination / Q000379:methods; D008727:Methotrexate / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D008727:Methotrexate